Silliman, Erin
Chung, Esther H.
Fitzpatrick, Elizabeth
Jolin, Julie A.
Brown, Michelle
Hotaling, James
Styer, Aaron K.
Karmon, Anatte E.
Article History
Received: 28 May 2022
Accepted: 17 August 2022
First Online: 1 September 2022
Declarations
:
: Institutional research ethics board (IRB) approval was obtained from Ethical & Independent Review Services IRB, a third-party IRB accredited by the Association for the Accreditation of Human Research Protection Programs. All methods were carried out in accordance with relevant guidelines and regulations as outlined in the Declaration of Helsinki.
: Not applicable.
: Dr. Chung, Dr. Jolin, Dr. Brown, Dr. Hotaling, Dr. Styer, and Dr. Karmon serve on the Clinical Advisory Board of Turtle Health. Their time for that work is compensated at fair market value, as was their time contributing to this study. Neither they, nor any other authors, own equity in Turtle Health, YourBio, or Accel Diagnostics. All other authors declare that they have no competing interests. Of note, Turtle Health made their supplier selection based on preliminary performance tests, resulting in a supply agreement with YourBio.